Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review.

Suppr

超能文献

作者信息

Erice A, Balfour H H

机构信息

Department of Laboratory Medicine, University of Minnesota Medical School, Minneapolis.

出版信息

Clin Infect Dis. 1994 Feb;18(2):149-56. doi: 10.1093/clinids/18.2.149.

DOI:10.1093/clinids/18.2.149

PMID:7512829

Abstract

摘要

相似文献

Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review.

Clin Infect Dis. 1994 Feb;18(2):149-56. doi: 10.1093/clinids/18.2.149.

[Reverse transcriptase inhibitors as anti-HIV agents].

Nihon Rinsho. 1993 Sep;51 Suppl:192-9.

Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.

J Virol. 1996 Feb;70(2):1086-90. doi: 10.1128/JVI.70.2.1086-1090.1996.

Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.

J Infect Dis. 1993 Aug;168(2):318-26. doi: 10.1093/infdis/168.2.318.

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.

AIDS. 1998 Jun 18;12(9):1015-20.

Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.

J Infect Dis. 2001 Sep 15;184(6):781-4. doi: 10.1086/323088. Epub 2001 Aug 7.

Antiretroviral therapy of human immunodeficiency virus type-1 (HIV-1) infection.

Aust N Z J Med. 1995 Aug;25(4):344-9. doi: 10.1111/j.1445-5994.1995.tb01900.x.

How to overcome resistance of HIV-1 to HIV-1-specific reverse transcriptase inhibitors.

AIDS. 1994 Jul;8(7):1020-1. doi: 10.1097/00002030-199407000-00028.

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.

Science. 1995 Aug 4;269(5224):696-9. doi: 10.1126/science.7542804.

[Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS].

Nihon Rinsho. 1991 Sep;49(9):2062-9.

引用本文的文献

Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an In vitro competitive HIV-1 replication assay.

J Virol. 1999 Jul;73(7):5356-63. doi: 10.1128/JVI.73.7.5356-5363.1999.

L-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytes.

Clin Diagn Lab Immunol. 1997 May;4(3):352-7. doi: 10.1128/cdli.4.3.352-357.1997.

A zidovudine-resistant simian immunodeficiency virus mutant with a Q151M mutation in reverse transcriptase causes AIDS in newborn macaques.

Antimicrob Agents Chemother. 1997 Feb;41(2):278-83. doi: 10.1128/AAC.41.2.278.

Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors.

J Virol. 1997 Feb;71(2):1089-96. doi: 10.1128/JVI.71.2.1089-1096.1997.

Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase.

J Virol. 1996 Dec;70(12):8821-32. doi: 10.1128/JVI.70.12.8821-8832.1996.

Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group.

J Clin Microbiol. 1996 Jul;34(7):1849-53. doi: 10.1128/JCM.34.7.1849-1853.1996.

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

EMBO J. 1996 Aug 1;15(15):4040-9.

Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.

J Virol. 1996 Jun;70(6):3392-400. doi: 10.1128/JVI.70.6.3392-3400.1996.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验